Recent Quotes

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-02
REV		(EXPECTED)2021-08-02

Q1 2021		Est.		Actual		Surprise
EPS		1.120		1.410		0.2900
REV		62.850M		55.150M		-7.700M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
LGND	Ligand Pharmaceuticals	123.82	0.76	0.62%		2.1B

Ligand Pharmaceuticals Frequently Asked Questions

How do I buy Ligand Pharmaceuticals (LGND) stock?

You can purchase shares of Ligand Pharmaceuticals (NASDAQ: LGND) through any online brokerage.

View our list of the best stock brokerages.

Who are Ligand Pharmaceuticals's (LGND) competitors?

Other companies in Ligand Pharmaceuticals’s space includes: bluebird bio (NASDAQ:BLUE), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cerevel Therapeutics Hldg (NASDAQ:CERE), FibroGen (NASDAQ:FGEN) and Prothena Corp (NASDAQ:PRTA).

What is the target price for Ligand Pharmaceuticals (LGND) stock?

The latest price target for Ligand Pharmaceuticals (NASDAQ: LGND) was reported by Barclays on May 4, 2021. The analyst firm set a price target for 190.00 expecting LGND to rise to within 12 months (a possible 53.45% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Ligand Pharmaceuticals (LGND)?

The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $123.82 last updated Tue Jun 15 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Ligand Pharmaceuticals (LGND) pay a dividend?

There are no upcoming dividends for Ligand Pharmaceuticals. The last dividend paid out to investors was $0.00 on April 3, 2007.

When is Ligand Pharmaceuticals (NASDAQ:LGND) reporting earnings?

Ligand Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 2, 2021.

Is Ligand Pharmaceuticals (LGND) going to split?

There is no upcoming split for Ligand Pharmaceuticals.

What sector and industry does Ligand Pharmaceuticals (LGND) operate in?

Ligand Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.